Construction of Eukaryotic Expression Vector with mBD1-mBD3 Fusion Genes and Exploring Its Activity against Influenza A Virus
Open Access
Abstract
Influenza (flu) pandemics have exhibited a great threat to human health throughout history. With the emergence of drug-resistant strains of influenza A virus (IAV), it is necessary to look for new agents for treatment and transmission prevention of the flu. Defensins are small (2–6 kDa) cationic peptides known for their broad-spectrum antimicrobial activity. Beta-defensins (β-defensins) are mainly produced by barrier epithelial cells and play an important role in attacking microbe invasion by epithelium. In this study, we focused on the anti-influenza A virus activity of mouse β-defensin 1 (mBD1) and β defensin-3 (mBD3) by synthesizing their fusion peptide with standard recombinant methods. The eukaryotic expression vectors pcDNA3.1(+)/mBD1-mBD3 were constructed successfully by overlap-PCR and transfected into Madin-Darby canine kidney (MDCK) cells. The MDCK cells transfected by pcDNA3.1(+)/mBD1-mBD3 were obtained by G418 screening, and the mBD1-mBD3 stable expression pattern was confirmed in MDCK cells by RT-PCR and immunofluorescence assay. The acquired stable transfected MDCK cells were infected with IAV (A/PR/8/34, H1N1, 0.1 MOI) subsequently and the virus titers in cell culture supernatants were analyzed by TCID50 72 h later. The TCID50 titer of the experimental group was clearly lower than that of the control group (p < 0.001). Furthermore, BALB/C mice were injected with liposome-encapsulated pcDNA3.1(+)/mBD1-mBD3 through muscle and then challenged with the A/PR/8/34 virus. Results showed the survival rate of 100% and lung index inhibitory rate of 32.6% in pcDNA3.1(+)/mBD1-mBD3group; the TCID50 titer of lung homogenates was clearly lower than that of the control group (p < 0.001). This study demonstrates that mBD1-mBD3 expressed by the recombinant plasmid pcDNA3.1(+)/mBD1-mBD3 could inhibit influenza A virus replication both in vitro and in vivo. These observations suggested that the recombinant mBD1-mBD3 might be developed into an agent for influenza prevention and treatment.Keywords
This publication has 27 references indexed in Scilit:
- Antimicrobial Human β-Defensins in the Colon and Their Role in Infectious and Non-Infectious DiseasesPathogens, 2013
- Differential localization and function of antibody-forming cells responsive to inactivated or live-attenuated influenza virus vaccinesInternational Immunology, 2012
- Transmissibility of Seasonal and Pandemic Influenza in a Cohort of Households in Hong Kong in 2009Epidemiology, 2011
- The Impact of Missed Opportunities on Seasonal Influenza Vaccination Coverage for Healthy Young ChildrenJournal of Public Health Management & Practice, 2011
- Antimicrobial Peptide Immunity Protects Human Nasal and Auricular Cartilage Against InfectionJournal of Craniofacial Surgery, 2010
- Emergence and pandemic potential of swine-origin H1N1 influenza virusNature, 2009
- Antimicrobial host defense in the upper gastrointestinal tractEuropean Journal of Gastroenterology & Hepatology, 2008
- Expression of Human Beta Defensin 4 in Genetically Modified Keratinocytes Enhances Antimicrobial ActivityJournal of Burn Care & Research, 2007
- Enhanced Surfactant Protein and Defensin mRNA Levels and Reduced Viral Replication during Parainfluenza Virus Type 3 Pneumonia in Neonatal LambsClinical and Vaccine Immunology, 2004
- Structure determination of human and murine β‐defensins reveals structural conservation in the absence of significant sequence similarityProtein Science, 2001